Position in REPL
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$1,855,997
-$734,227 QoQ
Shares Held
242,614
-9.0% QoQ
Ownership
0.289%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TD Asset Management Inc holds $1,314,505,240 across 121 Biotechnology names. REPL ranks #78 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
350,923 | $271,137,146 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
228,195 | $101,898,194 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
281,848 | $93,255,047 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,168,666 | $75,530,883 | |
| 5 | ARGX |
Argenx SE
|
80,824 | $59,021,726 | |
| 6 | ASND |
Ascendis Pharma A/S
|
217,992 | $49,861,310 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
529,954 | $39,794,245 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
317,811 | $30,907,119 |
All Filings in REPL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,855,997 | 242,614 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,590,224 | 266,484 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,190,177 | 284,052 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,042,029 | 327,452 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $2,689,557 | 275,852 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $3,563,948 | 294,298 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,823,537 | 257,622 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $2,249,460 | 249,940 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $1,951,371 | 238,846 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $2,256,255 | 267,646 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $4,579,423 | 267,646 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $3,107,370 | 133,823 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,552,982 | 144,563 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $3,616,593 | 132,963 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,813,367 | 105,001 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,835,417 | 105,001 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,995,540 | 117,523 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $3,478,583 | 128,361 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,461,211 | 116,775 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $4,006,245 | 104,275 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $2,240,562 | 73,437 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,510,308 | 65,801 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $476,514 | 20,700 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $514,395 | 20,700 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||